American Vanguard Invests in TyraTech Natural Product Technologies

  American Vanguard Invests in TyraTech Natural Product Technologies

Business Wire

NEWPORT BEACH, Calif. -- April 03, 2013

American Vanguard Corporation (NYSE:AVD) today announced that it has completed
an investment in TyraTech, Inc. to participate in the continued development
and marketing of natural products for human and animal health applications.
American Vanguard has invested $3.7 million to secure a 29.46% ownership
position in TyraTech, Inc.

American Vanguard’s equity investment achieves an important strategic
objective by expanding its involvement in the development of products derived
from natural sources and by participating in the penetration of such
technologies in non-agricultural market segments. TyraTech has developed more
than a dozen unique products that show efficacy as mosquito, fly, flea and
tick repellents, head lice control treatments and intestinal parasitic control
agents. Several of these products which are expected to be commercialized
during 2013 and 2014 demonstrate performance characteristics that are superior
to existing, commercially available, offerings. The global addressable market
potential for such applications is estimated to be in the range of $8 to 10
billion annually.

This investment follows the December 2012 creation of Envance Technologies,
LLC between AMVAC-Chemical Corporation (a wholly-owned subsidiary of American
Vanguard) and TyraTech, Inc. for the purpose of developing and commercializing
best-in-class technologies for the global consumer household and lawn & garden
retail markets. Envance Technologies, which is majority owned by
AMVAC-Chemical, already has its first commercial product line, Terminix®
Ultimate Protection, on the shelves of a major U.S. retail home improvement
chain. The global addressable market potential for such products is estimated
to be between $3.5 and 4.5 billion annually. Envance also expects to develop
new combinations of natural and synthetic compounds using TyraTech’s patented
Extend Technology®.

Eric Wintemute, Chairman & CEO of American Vanguard Corporation commented:
“This investment solidifies our commitment to the development and
commercialization of effective human and animal health products derived from
natural sources. American Vanguard’s existing non-crop business addresses
mosquito and general-purpose commercial pest control with a proven chemical
product portfolio. TyraTech’s advanced technology and product formulations
deploy natural defenses for individual protection from many threats that can
compromise human and animal health. Our ownership stake in TyraTech joins us
in a very complementary mission, with a clearly aligned mutual interest in
safeguarding both public and personal health.”

Alan Reade, Executive Chairman of TyraTech, Inc, commented: “The commitment
and support of American Vanguard gives confidence in our strategy and credence
to our belief that we are in the right markets with the right products. We are
seeing a significant and growing desire for products which are natural, safer
and more effective within our markets and we aim to be at the forefront of
this transformational shift in demand. We are most grateful for American
Vanguard’s support, which provides a solid foundation from which we can build
the TyraTech business.”

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural
products company that develops and markets products for crop protection and
management, turf and ornamentals management and public and animal health.
American Vanguard is included on the Russell 2000® & Russell 3000® Indexes and
the Standard & Poors 600 Index. To learn more about American Vanguard, please
reference the Company’s web site at www.american-vanguard.com.

About TyraTech

TyraTech, Inc. is a natural life sciences company that utilizes its
proprietary technology to develop solutions to address the unmet and
increasing global demand for effective, safe, and non-toxic insect and
parasite technologies for human and animal health. Founded in 2004, TyraTech
made its Initial Public Offering in June 2007 on the AIM section of the London
Stock Exchange, where it trades under the symbols TYR and TYRU. To learn more
about TyraTech, please visit the Company’s web site at www.tyratech.com.

Contact:

American Vanguard Corporation
William A. Kuser, 949-260-1200
Director of Investor Relations
williamk@amvac-chemical.com
or
The Equity Group Inc.
Lena Cati, 212-836-9611
Lcati@equityny.com
www.theequitygroup.com
 
Press spacebar to pause and continue. Press esc to stop.